-30%

est. 2Y upside i

HealthcareSeries C

Verse Medical is building the modern software infrastructure to make it happen. We're a well-funded Series C company (backed by General Catalyst, SignalFire, and Sapphire Ventures) on a mission to heal a fragmented system. Our platform connects the dots between providers, payors, and patients, ensuring people get the high-quality care they need, reliably and right where they live.

Rank

#2938

Sector

HealthTech, SaaS

Est. Liquidity

~3Y

Data Quality

Data: Medium

Verse Medical offers a high-risk equity opportunity with expected negative upside of ~30% over 2 years.

Last updated: July 19, 2026

Bull (20%)+135%

Revenue grows 70% then 50% to $51M, exit multiple holds at 36.8x driven by AI healthcare SaaS premium and strong market adoption, yielding $1.87B exit.

Base (55%)-65%

Multiple compresses to 8x as growth decelerates, exit valuation $408M, resulting in significant loss given entry at 36.8x multiple.

Bear (25%)-85%

Growth disappoints, multiple falls to 5x, exit $255M, and dilution further erodes common stock value; preference stack absorbs remaining value.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Funding Intensity

15%

Total preferred liquidation preference of $108M is 14.7% of entry valuation, so common equity retains upside above that level.

Dilution Risk

high

With $108M raised and only $5M ARR, the company likely burns cash quickly, requiring a dilutive round within 2 years.

Secondary Liquidity

moderate

Implied secondary valuation of $735M suggests some liquidity, but volume and frequency are uncertain.

Other — 4 roles

View all 4 open roles at Verse →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Verse's data — designed to show you've done your homework.

  • 1

    “How does Verse's DME optimization reduce friction for health systems, and what is the current customer acquisition cost?”

  • 2

    “Given the hybrid revenue model, what are the unit economics per patient and how do they scale?”

  • 3

    “What is the expected timeline to liquidity and key milestones for an IPO?”

Community

Valuation Sentiment

Our model estimates -30% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.